Literature DB >> 18070703

The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer.

Rob Glynne-Jones1, Pawan Mathur, Colin Elton, Matthew L Train.   

Abstract

Greater understanding of the natural history of rectal cancer, and the knowledge that a histologically involved circumferential margin due to inadequate lateral dissection confers a high risk of local recurrence have driven technical advances in surgical technique with meticulous surgical dissection along embryological planes. Significant improvements in local control and overall survival have been seen for patients with resectable rectal cancer. However, even high-quality surgery cannot always achieve a curative resection for locally advanced cancers that extend below the levators, having transgressed the mesorectal fascia. Magnetic resonance imaging is now accepted as a practical method of clinical staging, and can accurately predict pre-operatively the likelihood of achieving a clear circumferential margin. Technological advances in radiation planning and new effective cytotoxic drugs also give scope for dealing with unresectable rectal cancer, and the potential for controlling distant micrometastases. Hence, modern multimodal treatment of rectal cancer attempts to integrate surgery, radiotherapy and chemotherapy, and address the two distinct problems of local recurrence and metastatic disease. Multidisciplinary teams achieve the best results. This paper discusses the surgical management of rectal cancer, the pathology, the principles of imaging, and the lessons learnt from randomized trials of radiotherapy and chemoradiation.

Entities:  

Mesh:

Year:  2007        PMID: 18070703     DOI: 10.1016/j.bpg.2007.11.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy.

Authors:  Yifan Peng; Lin Wang; Changzheng Du; Jin Gu
Journal:  Int J Colorectal Dis       Date:  2012-05-30       Impact factor: 2.571

2.  Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report.

Authors:  Meijin Huang; Jinxin Lin; Xihu Yu; Shen Chen; Liang Kang; Yanhong Deng; Jian Zheng; Yanxin Luo; Lei Wang; Ping Lan; Jianping Wang
Journal:  Int J Colorectal Dis       Date:  2016-06-06       Impact factor: 2.571

3.  Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study.

Authors:  Chang-Zheng Du; Yong-Chun Chen; Yong Cai; Wei-Cheng Xue; Jin Gu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 4.  Does rectal tube/transanal stent placement after an anterior resection for rectal cancer reduce anastomotic leak? A systematic review and meta-analysis.

Authors:  Kay T Choy; Tze Wei Wilson Yang; Alexander Heriot; Satish K Warrier; Joseph C Kong
Journal:  Int J Colorectal Dis       Date:  2021-01-30       Impact factor: 2.571

Review 5.  Rectal cancer: An evidence-based update for primary care providers.

Authors:  Wolfgang B Gaertner; Mary R Kwaan; Robert D Madoff; Genevieve B Melton
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

6.  Quality of life, pain, anxiety and depression in patients surgically treated with cancer of rectum.

Authors:  Letácio José Freire Santos; João Batista dos Santos Garcia; Jairo Sousa Pacheco; Erica Brandão de Morais Vieira; Alcione Miranda dos Santos
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun

7.  In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer.

Authors:  Jun-xin Wu; Yu Wang; Na Chen; Lu-chuan Chen; Peng-gang Bai; Jian-ji Pan
Journal:  Radiat Oncol       Date:  2014-07-22       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.